Patent · US Expired

Therapeutic method for treatment of carcinoma or autoimmune diseases

US5780432A · kind A · utility

5Cited by

3References

4Claims

0Family size

Assignee

Allegheny University of the Health Sciences · US

Inventors

Michael Zeppezauer · Scheidt, DE
Reiner Class · Drexel Hill, US

Key dates

Filing date	Nov 22, 1996
Grant date	Jul 14, 1998
Priority date	—
Expiry date	Nov 22, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/1709
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A therapeutic method for treatment of carcinoma or autoimmune diseases of a patient, which includes administering to said patient a biologically active composition which comprises a therapeutically acceptable carrier and, in a quantity having a therapeutic effect, two active substances comprising a pure cytostatic drug as the first active substance and a biologically active pure histone selected from the group consisting of H1, H2A, H2B, H2A:H2B, and H3 as the second active substance, providing a synergistic action of both of said active substances at a site of pathogenic process of said patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.